BackZimmer Biomet Holdings Overview
Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings Target Price

Analysts' average 12-month price target for Zimmer Biomet Holdings is $100.

Get informed when a big investor buys or sells

+ Follow

Share Price

$88.29

Average Target Price

$104.3318.2% upside

9 analysts in the last 4 months

High: $120 | Low: $93

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-10Canaccord GenuityCaitlin Cronin$10013.3% upsideOpen
2026-08-06Truist Financial$10620.1% upsideOpen
2026-08-06Robert W. Baird$10417.8% upsideOpen
2026-08-06UBSPatrick Wood$12035.9% upsideOpen
2026-08-06Bernstein$935.3% upsideOpen
2026-08-06BMO Capital$968.7% upsideOpen
2026-08-06RBC CapitalKendall Au$11024.6% upsideOpen
2026-07-28UBSPatrick Wood$11530.3% upsideOpen
2026-07-08BMO Capital$957.6% upsideOpen
2026-04-29Truist Financial$924.2% upsideOpen
2026-04-29Canaccord Genuity$836% downsideOpen
2026-04-29Stifel NicolausRick Wise$10518.9% upsideOpen
2026-04-29Robert W. Baird$924.2% upsideOpen
2026-04-29BarclaysMatt Miksic$946.5% upsideOpen
2026-02-12BarclaysMatt Miksic$10013.3% upsideOpen
2026-02-11UBS$890.8% upsideOpen
2026-01-28UBS$862.6% downsideOpen
2026-01-09Bernstein$9912.1% upsideOpen
2026-01-09Goldman SachsDavid Roman$935.3% upsideOpen
2026-01-05Evercore ISI$12035.9% upsideOpen
2025-12-16Robert W. BairdJeff Johnson$10013.3% upsideOpen
2025-11-05Stifel NicolausRick Wise$11024.6% upsideOpen
2025-11-05Johnson Rice$11226.9% upsideOpen
2025-11-05Barclays$10518.9% upsideOpen
2025-10-13BTIGRyan Zimmerman$12238.2% upsideOpen
2025-10-10RBC Capital$11125.7% upsideOpen
2025-09-19Stifel Nicolaus$11833.7% upsideOpen
2025-09-18Redburn PartnersEd Ridley-Day$13047.2% upsideOpen
2025-08-08UBSDanielle Antalffy$968.7% upsideOpen
2025-05-06Truist FinancialRichard Newitter$10114.4% upsideOpen
2025-05-06RBC CapitalShagun Singh$11226.9% upsideOpen
2025-05-06Stifel NicolausRick Wise$11530.3% upsideOpen
2025-05-05Wells FargoLarry Biegelsen$9811% upsideOpen
2024-10-31Truist FinancialRichard Newitter$11732.5% upsideOpen
2024-10-15OppenheimerSteven Lichtman$13552.9% upsideOpen
2024-10-03BTIGRyan Zimmerman$12642.7% upsideOpen
2024-10-01Evercore ISIVijay Kumar$11024.6% upsideOpen
2024-09-13Truist FinancialRichard Newitter$11226.9% upsideOpen
2024-09-10Canaccord GenuityCaitlin Cronin$11530.3% upsideOpen
2024-08-08Raymond JamesJayson Bedford$12845% upsideOpen
2024-08-08OppenheimerSteven Lichtman$14564.2% upsideOpen
2024-08-07Stifel NicolausRick Wise$13047.2% upsideOpen
2024-07-15Morgan StanleyDrew Ranieri$12035.9% upsideOpen
2024-07-01Piper SandlerMatt O'Brien$11530.3% upsideOpen
2024-05-31Piper SandlerMatthew O\'Brien$14058.6% upsideOpen
2024-05-30RBC CapitalShagun Singh$14058.6% upsideOpen
2024-05-28BTIGRyan Zimmerman$13957.4% upsideOpen
2024-05-21Argus ResearchDavid Toung$15069.9% upsideOpen
2023-02-06Truist Financial$13755.2% upsideOpen
2023-02-06Morgan Stanley$14058.6% upsideOpen

Zimmer Biomet Holdings (ZBH) FAQ

Zimmer Biomet Holdings posts a target price of $100. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $100 for ZBH means covering analysts, on average, see the stock 18.2% upside of $88.29 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for ZBH's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Zimmer Biomet Holdings's other metric pages and overview cover the third.

Judging Zimmer Biomet Holdings against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in target price easier to interpret. Start with $100 here, then scan peer and history charts to see if the gap is persistent.